Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
0.00%
)
US TECH 100
28,493.60
(
0.48%
)
Dow Jones
49,526.17
(
0.00%
)
Brent Oil
105.18
(
-2.14%
)
Bitcoin
77,134.94
(
-0.35%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jq1234 post# 174530

Thursday, 02/20/2014 2:36:03 PM

Thursday, February 20, 2014 2:36:03 PM

Post# of 257580

Teva dropping Phase III laquinimod trial, Libretto.

Even though Teva/Active are continuing to run two other Laquinimod trials, I presume from your prior posts on this subject that you (as I do) ascribe little or no value to the Laquinimod program.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today